Application
WB analysis of extracts from HeLa cells, treated with IFNa or calf intestinal phosphatase (CIP), using mTOR (phospho Ser2448) antibody.Application
IHC-P analysis of human breast carcinomatissue using mTOR (phospho Ser2448) antibody.Application
Immunofluorescence staining of methanol-fixed MCF cells using mTOR(Phospho-Ser2448) AntibodyApplication
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using mTOR(Phospho-Ser2448) Antibody (left) or the same antibody preincubated with blocking peptide(right).Application
Western blot analysis of extracts from 293 cells untreated or treated with PMA using mTOR(Phospho-Ser2448) Antibody| Product Name | mTOR (phospho Ser2448) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to mTOR (phospho Ser2448)Kinase subunit of both mTORC1 and mTORC2, which regulate cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino-acids. Amino-acid-signaling to mTORC1 is mediated by Rag GTPases, which cause amino-acid-induced relocalization of mTOR within the endomembrane system. Growth factor-stimulated mTORC1 activation involves AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-421', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. mTORC2 is also activated by growth factors, but seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'. |
| Immunogen | Peptide sequence around phosphorylation site of serine 2448 (T-D-S(p)-Y-S) derived from Human mTOR. |
| Modification | p-Ser2448 |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ICC/IFIHC-PWB |
| Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100, ICC/IF: 1:100~1:200. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | FLJ44809 FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR FK506 binding protein 12-rapamycin associated protein 2 FK506-binding protein 12-rapamycin complex-associated protein 1 FKBP-rapamycin associated protein mammalian target of rapamycin rapamycin associa |
|---|---|
| Target | mTOR (phospho Ser2448) |
| Molecular Weight(MW) | 289 (note) |
Application
WB analysis of extracts from HeLa cells, treated with IFNa or calf intestinal phosphatase (CIP), using mTOR (phospho Ser2448) antibody.
Application
IHC-P analysis of human breast carcinomatissue using mTOR (phospho Ser2448) antibody.
Application
Immunofluorescence staining of methanol-fixed MCF cells using mTOR(Phospho-Ser2448) Antibody
Application
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using mTOR(Phospho-Ser2448) Antibody (left) or the same antibody preincubated with blocking peptide(right).
Application
Western blot analysis of extracts from 293 cells untreated or treated with PMA using mTOR(Phospho-Ser2448) Antibody| Application Notes | Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100, ICC/IF: 1:100~1:200. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
